PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease
Conditions
Crohn Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Calgary, Calgary, Alberta, Canada
Contact: Principal Investigator (Christopher Ma, MD MPH)Remo Panaccione, MD (Sub-investigator)University of Alberta IBD Clinic, Edmonton, Alberta, Canada
Contact: Principal Investigator (Frank Hoentjen, MD)GI Research Institute (G.I.R.I), Vancouver, British Columbia, Canada
Contact: Principal Investigator (Yvette Leung, MD)West Coast Gastroenterology, Vancouver, British Columbia, Canada
Contact: Principal Investigator (Sunny Singh, MD)Nova Scotia Health Victoria, Halifax, Nova Scotia, Canada
GNRR Digestive Clinics and Research Center Inc., Brampton, Ontario, Canada
Contact: Principal Investigator (Girsh Bajaj, MD)Rajbir Rai Medical Corporation, Brantford, Ontario, Canada
Contact: Principal Investigator (Rajbir Rai, MD)McMaster University, Hamilton, Ontario, Canada
Contact: Principal Investigator (Neeraj Narula, MD)London Health Sciences Centre, London, Ontario, Canada
West GTA Research Inc., Mississauga, Ontario, Canada
ABP Research Services Corp., Oakville, Ontario, Canada
Contact: Principal Investigator (Naveen Arya, MD)Taunton Surgical Center, Oshawa, Ontario, Canada
Contact: Principal Investigator (Daniel Green, MD)The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Contact: Principal Investigator (Sanjay Murthy, MD)Thunder Bay Regional Health Research Institute, Thunder Bay, Ontario, Canada
Mount Sinai Hospital, Toronto, Ontario, Canada
Contact: Principal Investigator (Laura Targownik, MD)TIDHI Clinic, Toronto, Ontario, Canada
Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada
Contact: Principal Investigator (Robert Battat, MD)Hôpital du Sacré-Cœur-de-Montréal, Montreal, Quebec, Canada
Contact: Principal Investigator (Jean-Frédéric LeBlanc, MD)Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec, Canada
Contact: Principal Investigator (Talat Bessisow, MD)Université de Sherbrooke, Sherbrooke, Quebec, Canada
Contact: Principal Investigator (Maxime Delisle, MD)